| 2026-04-01 22:00 | CC:MIR | MedMira Inc. | 0.065 | News Release200 | MedMira Reports Second Quarter Results FY2025 |
| 2026-04-01 21:24 | CC:MIR | Medmira Inc | | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2026-04-01 21:24 | CC:MIR | Medmira Inc | | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-12-30 20:04 | CC:MIR | Medmira Inc | 0.07 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-12-30 20:04 | CC:MIR | Medmira Inc | 0.07 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-12-30 20:00 | CC:MIR | MedMira Inc. | 0.07 | News Release200 | MedMira Reports First Quarter Results FY2026 |
| 2025-11-28 21:01 | CC:MIR | Medmira Inc | 0.075 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2025-11-28 21:01 | CC:MIR | Medmira Inc | 0.075 | SEDAR MD & A815 | SEDAR MD & A |
| 2025-11-28 21:00 | CC:MIR | MedMira Inc. | 0.075 | News Release200 | MedMira Reports FY2025 Fourth Quarter and Year End Financial Results |
| 2025-08-26 16:44 | CC:MIR | MedMira Inc. | 0.075 | News Release200 | Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis |
| 2025-07-07 16:25 | CC:MIR | Medmira Inc | 0.075 | News Release200 | Medmira begins Multiplo clinical trial |
| 2025-07-01 00:46 | CC:MIR | Medmira Inc | 0.08 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-07-01 00:46 | CC:MIR | Medmira Inc | 0.08 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-06-30 23:00 | CC:MIR | MedMira Inc. | 0.08 | News Release200 | MedMira Reports Second Quarter Results FY2025 |